HCW Biologics is trading 6.3% higher at $1.19, with no clear company-specific catalyst identified. - No company-specific announcement dated October 23 explains the gain; the latest listed release was an October 9 update on its planned IND application. - Broader market indicators provided are mixed to lower and do not clearly explain the move. Available evidence identifies no specific catalyst or trading-activity detail.